<SEC-DOCUMENT>0001169245-20-000038-index.html : 20200320
<SEC-HEADER>0001169245-20-000038.hdr.sgml : 20200320
<ACCEPTANCE-DATETIME>20200320161301
ACCESSION NUMBER:		0001169245-20-000038
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20200319
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
FILED AS OF DATE:		20200320
DATE AS OF CHANGE:		20200320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PhaseBio Pharmaceuticals Inc
		CENTRAL INDEX KEY:			0001169245
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				030375697
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38697
		FILM NUMBER:		20732124

	BUSINESS ADDRESS:	
		STREET 1:		1 GREAT VALLEY PARKWAY
		STREET 2:		SUITE 30
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		(610) 981-6500

	MAIL ADDRESS:	
		STREET 1:		1 GREAT VALLEY PARKWAY
		STREET 2:		SUITE 30
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Phase Biosciences Inc
		DATE OF NAME CHANGE:	20061013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DT BIOSCIENCES INC
		DATE OF NAME CHANGE:	20020315
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8-kxsvbconsent.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: a8-kxsvbconsent.htm

</DOCUMENT>
</SEC-DOCUMENT>